Inhibition of AQP4 has been found recently as therapy targeting central nervous system edema post-injury, including attenuating cerebral edema associated with ischemic stroke and eventually promoting neurological recovery (Sun et al. 2022). Here, AQP4 is linked to ischemic stroke.